Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT01053156
Eligibility Criteria:
Inclusion Criteria:
* Must have fragile X syndrome with molecular documentation
* Current pharmacological treatment regimen has been stable for at least 4 weeks
Exclusion Criteria:
* Subjects who plan to initiate or change pharmacologic or non-pharmacologic interventions during the course of the study
* subjects who are unable to take oral medication
* subjects who have been on minocycline previously
* subjects who are allergic to minocycline or tetracyclines
* subjects who are pregnant
* subjects with history of lupus or hepatic dysfunction
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
42 Months
Maximum Age:
16 Years
Study:
NCT01053156
Study Brief:
Protocol Section:
NCT01053156